[Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis]. 1965

A Orsini, and F Giraud, and P Bernard, and P Passeron

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000743 Anemia, Hemolytic A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES). Anemia, Hemolytic, Acquired,Anemia, Microangiopathic,Haemolytic Anaemia,Hemolytic Anemia,Hemolytic Anemia, Acquired,Microangiopathic Hemolytic Anemia,Acquired Hemolytic Anemia,Anaemia, Haemolytic,Anemia, Acquired Hemolytic,Anemia, Microangiopathic Hemolytic,Haemolytic Anaemias,Hemolytic Anemia, Microangiopathic,Microangiopathic Anemia,Microangiopathic Hemolytic Anemias
D012806 Siderosis A form of pneumoconiosis resulting from inhalation of iron in the mining dust or welding fumes. Sideroses
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias

Related Publications

A Orsini, and F Giraud, and P Bernard, and P Passeron
January 1967, Marseille medical,
A Orsini, and F Giraud, and P Bernard, and P Passeron
January 1968, Pediatrie,
A Orsini, and F Giraud, and P Bernard, and P Passeron
December 1964, Giornale di clinica medica,
A Orsini, and F Giraud, and P Bernard, and P Passeron
January 1968, Henry Ford Hospital medical journal,
A Orsini, and F Giraud, and P Bernard, and P Passeron
March 1964, Henry Ford Hospital medical bulletin,
A Orsini, and F Giraud, and P Bernard, and P Passeron
January 1964, Haematologica,
A Orsini, and F Giraud, and P Bernard, and P Passeron
January 1969, Rivista di patologia clinica e sperimentale,
A Orsini, and F Giraud, and P Bernard, and P Passeron
June 1965, Journal of the Iowa Medical Society,
A Orsini, and F Giraud, and P Bernard, and P Passeron
February 1983, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
A Orsini, and F Giraud, and P Bernard, and P Passeron
January 1972, Vutreshni bolesti,
Copied contents to your clipboard!